Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Mitochondrial ORF of the 12S rRNA Type-C
Mots-C is a mitochondrial-derived peptide that has been studied for metabolic regulation, exercise performance enhancement, and potential anti-aging effects.
Mots-C activates AMPK pathway, regulates metabolic homeostasis, and has been shown to improve glucose uptake and utilization. It may also enhance exercise capacity through improved mitochondrial function.
Preclinical studies in mice demonstrate improved insulin sensitivity, prevention of age-related metabolic dysfunction, and enhanced exercise capacity. Endogenous MOTS-c levels decline with age and correlate with metabolic fitness. Human trials are limited but emerging.
Typical Dose
5mg
Range
5-10mg
Frequency
3x/week (subcutaneous)
Route
SubQ
Duration
4-8 weeks
Reconstitution
10mg vial + 2mL bacteriostatic water = 5,000mcg/mL
Notes
Typically dosed 5 mg three to five times per week in research settings. Often cycled 4–8 weeks. Best administered on training days for potential synergistic effects with exercise.
These biomarkers are commonly tracked to assess response and safety. Run baseline labs before starting, mid-cycle labs halfway through, and post-cycle labs 1–2 weeks after the final dose.
Build a protocol with Mots-C, schedule blood work for key biomarkers, and track your results.
Build Protocol with Mots-CThis platform provides informational tools only, not medical advice. This information is for educational purposes only. Consult a licensed provider.